CN Stock MarketDetailed Quotes

603193 Runben Biotechnology

Watchlist
  • 35.58
  • +0.70+2.01%
Market Closed Apr 25 15:00 CST
14.40BMarket Cap46.63P/E (TTM)

Runben Biotechnology Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
Total operating revenue
44.00%240.03M
27.61%1.32B
25.98%1.04B
28.47%744.03M
10.02%166.68M
20.66%1.03B
20.90%823.53M
31.93%579.15M
151.5M
47.06%856.09M
Operating revenue
44.00%240.03M
27.61%1.32B
25.98%1.04B
28.47%744.03M
10.02%166.68M
20.66%1.03B
20.90%823.53M
31.93%579.15M
--151.5M
47.06%856.09M
Other operating revenue
----
17.66%773.95K
----
7.35%402.3K
----
49.30%657.8K
----
121.93%374.76K
----
85.75%440.6K
Total operating cost
49.78%195.09M
27.15%982.41M
21.23%741.94M
22.33%537.56M
0.86%130.26M
14.78%772.61M
16.53%611.99M
26.53%439.43M
129.15M
51.14%673.14M
Operating cost
37.58%101.6M
22.28%551.38M
19.61%432.28M
19.55%307.76M
3.36%73.85M
14.99%450.93M
15.47%361.4M
26.23%257.44M
--71.45M
43.47%392.15M
Operating tax surcharges
22.29%3.05M
55.87%14.83M
48.19%11.43M
63.70%8.53M
59.00%2.49M
7.21%9.52M
14.24%7.72M
49.95%5.21M
--1.57M
30.02%8.88M
Operating expense
50.23%75.49M
41.25%379.59M
35.57%282.9M
38.23%213.79M
14.68%50.25M
15.88%268.74M
18.22%208.67M
28.80%154.66M
--43.82M
72.50%231.91M
Administration expense
23.01%8.85M
-2.04%32.27M
5.73%21.45M
1.30%14.06M
2.82%7.19M
30.24%32.95M
9.70%20.29M
6.88%13.88M
--7M
20.74%25.3M
Financial expense
84.79%-1.58M
-102.08%-30.74M
-607.98%-30.74M
-462.85%-21.33M
-3,262.73%-10.41M
-230.23%-15.21M
-17.42%-4.34M
-65.26%-3.79M
---309.6K
-21.80%-4.61M
-Interest expense (Financial expense)
-34.14%25.11K
-48.67%131.57K
-48.27%105.03K
-57.00%69.12K
-59.71%38.12K
-40.20%256.3K
-34.41%203.02K
-29.58%160.77K
--94.62K
-20.25%428.6K
-Interest Income (Financial expense)
84.47%-1.63M
-99.05%-30.98M
-568.33%-30.92M
-435.50%-21.46M
-2,341.86%-10.46M
-203.16%-15.56M
-13.19%-4.63M
-56.90%-4.01M
---428.52K
-24.30%-5.13M
Research and development
11.75%7.69M
36.49%35.07M
34.83%24.61M
22.69%14.76M
22.26%6.88M
31.68%25.69M
29.13%18.26M
32.17%12.03M
--5.63M
43.46%19.51M
Credit Impairment Loss
-2.70%-437.08K
-229.17%-488.66K
-54.48%-606.02K
-747.78%-1.85M
-146.04%-425.58K
-320.14%-148.45K
38.90%-392.31K
31.83%-217.68K
---172.97K
-1,350.82%-35.33K
Asset Impairment Loss
32.97%-1.68M
24.50%-1.82M
-1,003.94%-2.36M
-930.84%-4.15M
-746.06%-2.51M
-113.42%-2.41M
63.55%-213.94K
32.43%-403.07K
---296.09K
53.10%-1.13M
Adjustment items of total operating cost
----
----
----
----
----
----
--0.01
----
----
----
Other net revenue
494.89%5.54M
165.18%11.33M
-38.40%3M
-195.46%-1.52M
-4,205.82%-1.4M
49.78%4.27M
235.04%4.87M
75.19%1.59M
-32.56K
-30.66%2.85M
Fair value change income
--4.77M
--3.59M
----
----
----
----
----
----
----
----
Invest income
919.25%1.54M
360.11%3.86M
106.74%1.03M
345.17%472.72K
731.16%151.35K
-59.05%838.63K
-58.10%499.65K
-86.09%106.19K
--18.21K
4.58%2.05M
Asset deal income
99.31%-1.44K
-704.17%-507.89K
-382.42%-236.92K
-381.83%-236.92K
---210.51K
77.67%84.06K
--83.89K
--84.06K
--0
4,681.75%47.31K
Other revenue
-15.19%1.35M
13.34%6.7M
5.73%5.17M
110.29%4.25M
279.59%1.59M
207.32%5.91M
228.34%4.89M
90.66%2.02M
--418.29K
-57.84%1.92M
Operating profit
44.11%50.47M
31.17%347.1M
37.97%298.57M
45.03%204.94M
56.91%35.02M
42.42%264.62M
37.46%216.4M
52.60%141.31M
22.32M
31.88%185.8M
Add:Non operating Income
-99.30%35.01K
54.78%5.14M
1,634.56%5.08M
9,551.06%5.04M
41,541.59%5.03M
34.20%3.32M
-87.79%292.73K
-97.73%52.19K
--12.07K
146.38%2.47M
Less:Non operating expense
1,223.70%109K
2,057.60%231.52K
2,106.28%112.13K
5,495.12%9.84K
7,740.97%8.23K
1,687.20%10.73K
1,879.70%5.08K
430.07%175.93
--105.02
-99.77%600.4
Total profit
25.87%50.4M
31.38%352M
40.08%303.54M
48.54%209.97M
79.30%40.04M
42.31%267.93M
35.58%216.69M
48.96%141.36M
22.33M
32.93%188.27M
Less:Income tax cost
35.73%6.2M
23.73%51.84M
18.62%42.65M
36.79%29.94M
277.89%4.57M
48.43%41.9M
26.83%35.96M
33.87%21.89M
--1.21M
34.52%28.23M
Net profit
24.60%44.2M
32.80%300.16M
44.35%260.88M
50.69%180.03M
67.93%35.47M
41.23%226.03M
37.47%180.73M
52.10%119.47M
21.12M
32.66%160.04M
Net profit from continuing operation
24.60%44.2M
32.80%300.16M
44.35%260.88M
50.69%180.03M
67.93%35.47M
41.23%226.03M
37.47%180.73M
--119.47M
--21.12M
32.66%160.04M
Net profit of parent company owners
24.60%44.2M
32.80%300.16M
44.35%260.88M
50.69%180.03M
67.93%35.47M
41.23%226.03M
37.47%180.73M
52.10%119.47M
--21.12M
32.66%160.04M
Earning per share
Basic earning per share
22.22%0.11
15.63%0.74
20.75%0.64
25.71%0.44
50.00%0.09
36.17%0.64
39.47%0.53
52.17%0.35
--0.06
30.56%0.47
Diluted earning per share
22.22%0.11
15.63%0.74
20.75%0.64
25.71%0.44
50.00%0.09
36.17%0.64
39.47%0.53
52.17%0.35
--0.06
30.56%0.47
Other composite income
Total composite income
24.60%44.2M
32.80%300.16M
44.35%260.88M
50.69%180.03M
67.93%35.47M
41.23%226.03M
37.47%180.73M
52.10%119.47M
21.12M
32.66%160.04M
Total composite income of parent company owners
24.60%44.2M
32.80%300.16M
44.35%260.88M
50.69%180.03M
67.93%35.47M
41.23%226.03M
37.47%180.73M
52.10%119.47M
--21.12M
32.66%160.04M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Guangdong Sinong Accounting Firm (Special General Partnership)
--
--
--
Guangdong Sinong Accounting Firm (Special General Partnership)
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022
Total operating revenue 44.00%240.03M27.61%1.32B25.98%1.04B28.47%744.03M10.02%166.68M20.66%1.03B20.90%823.53M31.93%579.15M151.5M47.06%856.09M
Operating revenue 44.00%240.03M27.61%1.32B25.98%1.04B28.47%744.03M10.02%166.68M20.66%1.03B20.90%823.53M31.93%579.15M--151.5M47.06%856.09M
Other operating revenue ----17.66%773.95K----7.35%402.3K----49.30%657.8K----121.93%374.76K----85.75%440.6K
Total operating cost 49.78%195.09M27.15%982.41M21.23%741.94M22.33%537.56M0.86%130.26M14.78%772.61M16.53%611.99M26.53%439.43M129.15M51.14%673.14M
Operating cost 37.58%101.6M22.28%551.38M19.61%432.28M19.55%307.76M3.36%73.85M14.99%450.93M15.47%361.4M26.23%257.44M--71.45M43.47%392.15M
Operating tax surcharges 22.29%3.05M55.87%14.83M48.19%11.43M63.70%8.53M59.00%2.49M7.21%9.52M14.24%7.72M49.95%5.21M--1.57M30.02%8.88M
Operating expense 50.23%75.49M41.25%379.59M35.57%282.9M38.23%213.79M14.68%50.25M15.88%268.74M18.22%208.67M28.80%154.66M--43.82M72.50%231.91M
Administration expense 23.01%8.85M-2.04%32.27M5.73%21.45M1.30%14.06M2.82%7.19M30.24%32.95M9.70%20.29M6.88%13.88M--7M20.74%25.3M
Financial expense 84.79%-1.58M-102.08%-30.74M-607.98%-30.74M-462.85%-21.33M-3,262.73%-10.41M-230.23%-15.21M-17.42%-4.34M-65.26%-3.79M---309.6K-21.80%-4.61M
-Interest expense (Financial expense) -34.14%25.11K-48.67%131.57K-48.27%105.03K-57.00%69.12K-59.71%38.12K-40.20%256.3K-34.41%203.02K-29.58%160.77K--94.62K-20.25%428.6K
-Interest Income (Financial expense) 84.47%-1.63M-99.05%-30.98M-568.33%-30.92M-435.50%-21.46M-2,341.86%-10.46M-203.16%-15.56M-13.19%-4.63M-56.90%-4.01M---428.52K-24.30%-5.13M
Research and development 11.75%7.69M36.49%35.07M34.83%24.61M22.69%14.76M22.26%6.88M31.68%25.69M29.13%18.26M32.17%12.03M--5.63M43.46%19.51M
Credit Impairment Loss -2.70%-437.08K-229.17%-488.66K-54.48%-606.02K-747.78%-1.85M-146.04%-425.58K-320.14%-148.45K38.90%-392.31K31.83%-217.68K---172.97K-1,350.82%-35.33K
Asset Impairment Loss 32.97%-1.68M24.50%-1.82M-1,003.94%-2.36M-930.84%-4.15M-746.06%-2.51M-113.42%-2.41M63.55%-213.94K32.43%-403.07K---296.09K53.10%-1.13M
Adjustment items of total operating cost --------------------------0.01------------
Other net revenue 494.89%5.54M165.18%11.33M-38.40%3M-195.46%-1.52M-4,205.82%-1.4M49.78%4.27M235.04%4.87M75.19%1.59M-32.56K-30.66%2.85M
Fair value change income --4.77M--3.59M--------------------------------
Invest income 919.25%1.54M360.11%3.86M106.74%1.03M345.17%472.72K731.16%151.35K-59.05%838.63K-58.10%499.65K-86.09%106.19K--18.21K4.58%2.05M
Asset deal income 99.31%-1.44K-704.17%-507.89K-382.42%-236.92K-381.83%-236.92K---210.51K77.67%84.06K--83.89K--84.06K--04,681.75%47.31K
Other revenue -15.19%1.35M13.34%6.7M5.73%5.17M110.29%4.25M279.59%1.59M207.32%5.91M228.34%4.89M90.66%2.02M--418.29K-57.84%1.92M
Operating profit 44.11%50.47M31.17%347.1M37.97%298.57M45.03%204.94M56.91%35.02M42.42%264.62M37.46%216.4M52.60%141.31M22.32M31.88%185.8M
Add:Non operating Income -99.30%35.01K54.78%5.14M1,634.56%5.08M9,551.06%5.04M41,541.59%5.03M34.20%3.32M-87.79%292.73K-97.73%52.19K--12.07K146.38%2.47M
Less:Non operating expense 1,223.70%109K2,057.60%231.52K2,106.28%112.13K5,495.12%9.84K7,740.97%8.23K1,687.20%10.73K1,879.70%5.08K430.07%175.93--105.02-99.77%600.4
Total profit 25.87%50.4M31.38%352M40.08%303.54M48.54%209.97M79.30%40.04M42.31%267.93M35.58%216.69M48.96%141.36M22.33M32.93%188.27M
Less:Income tax cost 35.73%6.2M23.73%51.84M18.62%42.65M36.79%29.94M277.89%4.57M48.43%41.9M26.83%35.96M33.87%21.89M--1.21M34.52%28.23M
Net profit 24.60%44.2M32.80%300.16M44.35%260.88M50.69%180.03M67.93%35.47M41.23%226.03M37.47%180.73M52.10%119.47M21.12M32.66%160.04M
Net profit from continuing operation 24.60%44.2M32.80%300.16M44.35%260.88M50.69%180.03M67.93%35.47M41.23%226.03M37.47%180.73M--119.47M--21.12M32.66%160.04M
Net profit of parent company owners 24.60%44.2M32.80%300.16M44.35%260.88M50.69%180.03M67.93%35.47M41.23%226.03M37.47%180.73M52.10%119.47M--21.12M32.66%160.04M
Earning per share
Basic earning per share 22.22%0.1115.63%0.7420.75%0.6425.71%0.4450.00%0.0936.17%0.6439.47%0.5352.17%0.35--0.0630.56%0.47
Diluted earning per share 22.22%0.1115.63%0.7420.75%0.6425.71%0.4450.00%0.0936.17%0.6439.47%0.5352.17%0.35--0.0630.56%0.47
Other composite income
Total composite income 24.60%44.2M32.80%300.16M44.35%260.88M50.69%180.03M67.93%35.47M41.23%226.03M37.47%180.73M52.10%119.47M21.12M32.66%160.04M
Total composite income of parent company owners 24.60%44.2M32.80%300.16M44.35%260.88M50.69%180.03M67.93%35.47M41.23%226.03M37.47%180.73M52.10%119.47M--21.12M32.66%160.04M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Guangdong Sinong Accounting Firm (Special General Partnership)------Guangdong Sinong Accounting Firm (Special General Partnership)------Rong Cheng Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More